Michael E. Minshall

2.2k total citations
34 papers, 1.8k citations indexed

About

Michael E. Minshall is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Surgery. According to data from OpenAlex, Michael E. Minshall has authored 34 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Economics and Econometrics and 6 papers in Surgery. Recurrent topics in Michael E. Minshall's work include Diabetes Management and Research (17 papers), Diabetes Treatment and Management (16 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Michael E. Minshall is often cited by papers focused on Diabetes Management and Research (17 papers), Diabetes Treatment and Management (16 papers) and Health Systems, Economic Evaluations, Quality of Life (12 papers). Michael E. Minshall collaborates with scholars based in United States, United Kingdom and Switzerland. Michael E. Minshall's co-authors include Wei Shen, Andrew Palmer, William J. Valentine, Stéphane Roze, V. Foos, Sandra L. Tunis, Giatgen A. Spinas, Morten Lammert, Paul Lips and Stuart L. Silverman and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes and The Journal of Infectious Diseases.

In The Last Decade

Michael E. Minshall

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Minshall United States 18 741 640 524 266 215 34 1.8k
Richard L. Bauer United States 22 151 0.2× 169 0.3× 517 1.0× 62 0.2× 314 1.5× 42 1.3k
Johanna H. M. Driessen Netherlands 21 413 0.6× 332 0.5× 355 0.7× 15 0.1× 331 1.5× 86 1.3k
C E Chilvers United Kingdom 18 112 0.2× 252 0.4× 168 0.3× 23 0.1× 85 0.4× 26 1.2k
D.A. Hanley Canada 7 37 0.0× 723 1.1× 1.1k 2.1× 50 0.2× 231 1.1× 9 1.5k
Chatlert Pongchaiyakul Thailand 20 143 0.2× 483 0.8× 616 1.2× 10 0.0× 217 1.0× 92 1.3k
Carlen Reyes Spain 18 48 0.1× 402 0.6× 292 0.6× 53 0.2× 177 0.8× 48 1.3k
Shih-Wei Lai Taiwan 15 122 0.2× 302 0.5× 35 0.1× 64 0.2× 188 0.9× 32 1.0k
Rafael Pinedo‐Villanueva United Kingdom 20 36 0.0× 712 1.1× 118 0.2× 85 0.3× 66 0.3× 89 1.4k
Robert A. Bear Canada 25 84 0.1× 453 0.7× 26 0.0× 59 0.2× 293 1.4× 78 1.6k
Jackson Tang United States 14 34 0.0× 165 0.3× 85 0.2× 126 0.5× 68 0.3× 49 914

Countries citing papers authored by Michael E. Minshall

Since Specialization
Citations

This map shows the geographic impact of Michael E. Minshall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Minshall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Minshall more than expected).

Fields of papers citing papers by Michael E. Minshall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Minshall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Minshall. The network helps show where Michael E. Minshall may publish in the future.

Co-authorship network of co-authors of Michael E. Minshall

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Minshall. A scholar is included among the top collaborators of Michael E. Minshall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Minshall. Michael E. Minshall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Tunis, Sandra L. & Michael E. Minshall. (2009). Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US. Current Medical Research and Opinion. 26(1). 151–162. 22 indexed citations
5.
Tunis, Sandra L. & Michael E. Minshall. (2008). Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the united states.. PubMed. 14(3). 131–40. 45 indexed citations
6.
Valentine, William J., Daniel Tucker, Cheryl Silberman, et al.. (2008). Long-Term Cost-Effectiveness of Pioglitazone versus Placebo in Addition to Existing Diabetes Treatment: A US Analysis Based on PROactive. Value in Health. 12(1). 1–9. 13 indexed citations
7.
Tunis, Sandra L., et al.. (2008). Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US. Current Medical Research and Opinion. 24(11). 3085–3096. 7 indexed citations
8.
Pelletier, Elise M., Paula Smith, Kristina S. Boye, et al.. (2008). Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting. Applied Health Economics and Health Policy. 6(2-3). 103–112. 52 indexed citations
9.
Minshall, Michael E., Alan Oglesby, Matthew Wintle, et al.. (2007). Estimating the Long-Term Cost-Effectiveness of Exenatide in the United States: An Adjunctive Treatment for Type 2 Diabetes Mellitus. Value in Health. 11(1). 22–33. 36 indexed citations
10.
11.
Cohen, Neale, et al.. (2007). Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections of Insulin. PharmacoEconomics. 25(10). 881–897. 36 indexed citations
12.
Watkins, John B., Michael E. Minshall, & Sean D. Sullivan. (2006). Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience. Journal of Managed Care Pharmacy. 12(9). 726–735. 34 indexed citations
13.
Minshall, Michael E., Stéphane Roze, Andrew Palmer, et al.. (2005). Treating diabetes to accepted standards of care: A 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States. Clinical Therapeutics. 27(6). 940–950. 34 indexed citations
14.
Palmer, Andrew, Stéphane Roze, William J. Valentine, et al.. (2004). What Impact Would Pancreatic Beta-cell Preservation Have on Life Expectancy, Quality-adjusted Life Expectancy and Costs of Complications in Patients with Type 2 Diabetes? A Projection Using the CORE Diabetes Model. Current Medical Research and Opinion. 20(sup1). S59–S66. 13 indexed citations
15.
Palmer, Andrew, Stéphane Roze, William J. Valentine, et al.. (2004). Deleterious Effects of Increased Body Weight Associated with Intensive Insulin Therapy for Type 1 Diabetes: Increased Blood Pressure and Worsened Lipid Profile Partially Negate Improvements in Life Expectancy. Current Medical Research and Opinion. 20(sup1). S67–S73. 13 indexed citations
16.
Oglesby, Alan, et al.. (2003). The impact of incident vertebral and non-vertebral fragility fractures on health-related quality of life in established postmenopausal osteoporosis: results from the teriparatide randomized, placebo-controlled trial in postmenopausal women.. PubMed. 30(7). 1579–83. 35 indexed citations
17.
Minshall, Michael E., et al.. (1999). Pharmacoeconomics Research Credibility. Medical Care. 37(4 Suppl Lilly). AS12–AS19. 6 indexed citations
18.
Minshall, Michael E., et al.. (1995). Integrating a Global Health Economics Study within a Phase III Clinical Trial. Drug Information Journal. 29(4). 1191–1199. 2 indexed citations
19.
Mahoney, Sandy, Madeleine Duvic, B J Nickoloff, et al.. (1991). Human immunodeficiency virus (HIV) transcripts identified in HIV-related psoriasis and Kaposi's sarcoma lesions.. Journal of Clinical Investigation. 88(1). 174–185. 65 indexed citations
20.
Lewis, D E, Michael E. Minshall, Naomi R. Wray, et al.. (1990). Confocal Microscopic Detection of Human Immunodeficiency Virus RNA-Producing Cells. The Journal of Infectious Diseases. 162(6). 1373–1378. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard L. Bauer Breakdown of academic impact, for papers by Johanna H. M. Driessen Breakdown of academic impact, for papers by C E Chilvers Breakdown of academic impact, for papers by D.A. Hanley Breakdown of academic impact, for papers by Chatlert Pongchaiyakul Breakdown of academic impact, for papers by Carlen Reyes Breakdown of academic impact, for papers by Shih-Wei Lai Breakdown of academic impact, for papers by Rafael Pinedo‐Villanueva Breakdown of academic impact, for papers by Robert A. Bear Breakdown of academic impact, for papers by Jackson Tang
Rankless by CCL
2026